Ralf Elvert

Philipps University of Marburg — Germany

Medicine · Health Sciences

21h-index2.5kcitations48works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Treatment and Management(9), Regulation of Appetite and Obesity(6), Adipose Tissue and Metabolism(6), Diet and metabolism studies(6), Neuropeptides and Animal Physiology(5)

Publications48 total

Novel tricyclic small molecule inhibitors of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
Scientific Reports·2022· 24 citedOpen Access
Analysis of 16 studies in nine rodent models does not support the hypothesis that diabetic polyuria is a main reason of urinary bladder enlargement
Frontiers in Physiology·2022· 8 citedOpen Access
Insulin is Not Driving Urinary Bladder Enlargement in Rodent Models of Diabetes
The FASEB Journal·2022
Author Correction: EMPReSS: standardized phenotype screens for functional annotation of the mouse genome
Nature Genetics·2022
Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
Cell Metabolism·2021· 160 citedOpen Access
Urinary bladder enlargement across nine rodent models of diabetes: correlations with glucose and insulin levels
2021Open Access
Hepatic Deletion of Nicotinamide N-Methyltransferase Prevents Body Weight Gain and Improves Insulin Sensitivity in Mice on Standard Diet
Diabetologie und Stoffwechsel·2021
The Novel Phosphate and Bile Acid Sequestrant Polymer SAR442357 Delays Disease Progression in a Rat Model of Diabetic Nephropathy
Journal of Pharmacology and Experimental Therapeutics·2020· 14 cited
Multiparameter Peptide Optimization toward Stable Triple Agonists for the Treatment of Diabetes and Obesity
Advanced Therapeutics·2020· 8 cited
Activation of Adenosine Monophosphate—Activated Protein Kinase Reduces the Onset of Diet‐Induced Hepatocellular Carcinoma in Mice
Hepatology Communications·2020· 7 citedOpen Access
Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis
Diabetes Obesity and Metabolism·2020· 37 citedOpen Access
Author response for "Incretin combination therapy for the treatment of non-alcoholic steatohepatitis"
2020Open Access
Genetic Nicotinamide <i>N</i>-Methyltransferase (<i>Nnmt</i>) Deficiency in Male Mice Improves Insulin Sensitivity in Diet-Induced Obesity but Does Not Affect Glucose Tolerance
Diabetes·2018· 57 cited
Cover Image, Volume 20, Issue 8
Diabetes Obesity and Metabolism·2018Open Access
Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys
Endocrinology·2018· 23 citedOpen Access
Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates
Diabetes Obesity and Metabolism·2018· 40 citedOpen Access
Weight Loss Outcomes with Species-Specific Dual GLP-1R/GCGR Agonists in Animal Models
Diabetes·2018
Genetic Nicotinamide N-Methyltransferase Deficiency Improves Insulin Sensitivity in DIO Mice
Diabetes·2018
Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations
Journal of Medicinal Chemistry·2018· 49 citedOpen Access
A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders
Scientific Reports·2018· 96 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Aimo Kannt(16), Martin Hrabě de Angelis(11), Martin Bossart(11), Michael Wagner(11), Helmut Fuchs(10), Andreas Evers(10), Gerhard Heldmaier(9), Valérie Gailus‐Durner(9), Martin Klingenspor(9), Andreas W. Herling(9), Torsten Haack(9), Katrin Lorenz(8), Nicole Ehrhardt(7), Eckhard Wolf(7), M. Lorenz(7), Sabine M. Hölter(6), Thomas Klopstock(6), Wolfgang Wurst(6), Angela Dudda(6), Jan Rozman(6)